参考图片
Expression of IL-10 by stimulated CD14+ human monocytes. Human PBMC were stimulated for 24 hr with LPS (1.0 ug/ml final concentration) in the presence of GolgiStop™ (Cat. No. 554724; 2 µM final concentration). The PBMC were harvested, stained with FITC Mouse Anti-Human CD14 antibody (Cat. No. 555397), fixed, permeabilized, and subsequently stained with 0.25 µg of PE Rat Anti-Human IL-10 antibody (Cat. No. 554706/559330/562035) following BD Pharmingen's staining protocol (see image, left panel). The data reflect gating on monocytes, based on forward and side scatter. To demonstrate specificity of staining, the binding of PE Rat Anti-Human IL-10 was blocked by the preincubation of the conjugated antibody with recombinant human IL-10 (0.25 µg, Cat. No. 554611; middle panel), and by preincubation of the fixed/permeabilized cells with Purified Rat Anti-Human IL-10 antibody (5.0 µg, Cat. No. 554705/554704; right panel) prior to staining with the PE Rat Anti-Human IL-10 antibody. The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified with the recombinant cytokine blocking (middle panel) and unlabelled antibody (right panel) blocking specificity controls.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9713.html